Coming of age and building of bridges … reflections on the past, present, and, hesitatingly, future
Irwin M. Arias – 3 March 2017
Overview of causality assessment in drug‐induced liver injury
Paul H. Hayashi – 1 March 2017
What can we learn from other clinical settings on the influence of the gut microbiome on the brain?
Eamonn M. M. Quigley – 1 March 2017
The role of the hepatopathologist in the assessment of drug‐induced liver injury
David E. Kleiner – 1 March 2017
Novel treatments targeting metabolic and signaling mechanisms in primary biliary cholangitis
Claudia D. Fuchs, Emina Halilbasic, Michael Trauner – 1 March 2017
Interleukin‐6: The dark side of liver regeneration in chronic liver disease
Andreas Geier, Daniel Jahn, Heike M. Hermanns – 1 March 2017
Laboratory‐based biomarkers to improve causality assessment in drug‐induced liver injury
Daniel J. Antoine – 1 March 2017
LiverLearning®: 2018 Webinar: Portal Vein Thrombosis in Cirrhosis: Causes and Consequences
This webinar will focus on the concept of coagulation in cirrhosis; pathophysiology, concept of a rebalanced coagulation state in cirrhosis and the consequences such as portal vein thrombosis. The management of PVT will be discussed.Andres Cardenas (Moderator) Dr. Andrés Cárdenas is currently a Consultant and Clinical Professor of the Institute of Digestive Diseases and Metabolism at Hospital Clinic and University of Barcelona.